Protean eGov Technologies Faces Market Challenges Amid Broader Index Resilience
Protean eGov Technologies has reached a new 52-week low, reversing a seven-day decline. The stock is trading below key moving averages, reflecting a challenging market position. Over the past year, it has underperformed compared to the broader market, with declining operating profits and recent quarterly losses raising concerns about future growth.
Protean eGov Technologies, a small-cap player in the Computers - Software & Consulting industry, has experienced significant activity today, hitting a new 52-week low of Rs. 876.05. This decline marks a notable trend reversal, as the stock has gained after seven consecutive days of falling prices. Despite this uptick, Protean eGov is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position.In comparison, the broader market has shown resilience, with the Sensex rising by 0.88% to close at 82,078.59, just 4.75% shy of its 52-week high. Over the past year, Protean eGov has underperformed significantly, with a return of -27.62%, contrasting sharply with the Sensex's positive performance of 5.94%.
Financial metrics reveal a concerning trend for Protean eGov, as operating profit has declined at an annual rate of -14.79% over the last five years. Recent quarterly results also reflect a drop in profit before tax and profit after tax, raising questions about the company's long-term growth prospects. Despite a low debt-to-equity ratio and high institutional holdings at 38.7%, the stock's valuation remains high, with a price-to-book ratio of 3.8.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
